glp-1 obesity drug news today sep 30 2025 Alarming rise in weight loss overdoses Weight loss drug giants prepare

The 2024 study from the InfantRisk Center at Texas Tech University tested breast milk from eight women using injectable semaglutide and didnt find the drug in any of the 24 samples

Despite their abundance, ASPC heterogeneity remains less well characterized compared to adipocytes or immune cells

Fertility, Pregnancy Planning, and GLP-1 Therapy GLP-1 medications are not recommended during pregnancy because safety data in pregnant individuals remains limited

Semaglutide and tirzepatide had predecessor drugs in their same class that the FDA had already reviewed (liraglutide and native GIP, respectively)

Noom Weight is open to all adultsthere are no medical or BMI requirements to join

Science 320 , 12241229 (2008)